. The company’s pipeline involves four scientific-stage therapies. Its most Innovative drug candidate is ROS1 inhibitor taletrectinib for dealing with lung most cancers. Nuvation is finishing two section 2 pivotal reports on taletrectinib. On April 11, following publishing many tweets critical on the company, Musk announced he experienced determined https://financefeeds.com/eurex-to-launch-euro-eu-bond-futures-in-september-2025/